ARCHIVES

ODAC Recommends Approval of Evista for Breast Cancer Risk Reduction.

This article is from The Cancer Letter archive.

Vol. 33 No. 29 | July 27, 2007

Download PDF Visit The Full Archive

Related Articles

DCPC Advisor O Trial Of Cervical Lesion Management With HPV

June 3, 1994

Biomarker May Predict Prostate Cancer Metastases

December 27, 2013

In Brief: Community ASSN. Developing Clinical Standards Catalogue; Perry Leaves NCI For NIH Position

November 15, 1974

Peers Puzzled By Herberman’s Stance On Cell Phones While Believers Rally.

August 1, 2008

Funding Opportunities: NCI Accepts apploications For Cooperative Group Awards

February 12, 1999

In Brief: Big Ten Cancer Research Consortium Names Executive Officer

May 30, 2014